RealFeedApp BIO's plan includes seven priorities for Congress
BIO unveiled seven priorities and proposed a White House office to accelerate drug development and strengthen clinical trial infrastructure.
- Field
- industry news
- What they did
- A lobbying group called BioPharma Initiative unveiled an action plan designed to help the U.S. maintain its global leadership in biotechnology.
- Why it matters
- The plan outlines seven priorities for Congress and the Trump administration to accelerate drug development, improve clinical trial infrastructure, attract investment, and support biomedical research.
#biotechnology#policy#clinical trial#drug development#white house
